- Home
- Supplements
- Vitamin D
- Endometriosis
Vitamin D for Endometriosis
Low vitamin D status is associated with endometriosis severity, and small trials suggest supplementation reduces pelvic pain, but lesion outcomes are untested.
Overview
Verdict
Low vitamin D status is associated with endometriosis severity, and small trials report reduced pelvic pain with supplementation — but lesion outcomes are untested.
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- Test first; correct deficiency per standard guidance (commonly 1000-2000 IU daily maintenance)
- Expected timeframe
- 3 months for pain-signal assessment
Protocol
- notes
- Take with a fat-containing meal
- dosage
- Test 25-OH vitamin D first; correct deficiency per standard guidance, commonly 1000-2000 IU daily maintenance
- duration
- 3 months, then recheck levels and reassess
Evidence
What the studies say
Effects of Vitamin D on Endometriosis-Related Pain: A Double-Blind Clinical Trial
Almassinokiani F, Khodaverdi S, Solaymani-Dodaran M +2 more
we did not find significant differences in severity of pelvic pain (p=0.24) and dysmenorrhea (p=0.45) between the 2 groups
Antioxidant vitamins supplementation reduce endometriosis related pelvic pain in humans: a systematic review and meta-analysis
Zheng SH, Chen XX, Chen Y +3 more
antioxidant vitamins supplementation reduce endometriosis related pelvic pain in humans
Supplementation with vitamin D or omega-3 fatty acids in adolescent girls and young women with endometriosis (SAGE): a double-blind, randomized, placebo-controlled trial
Nodler JL, DiVasta AD, Vitonis AF +3 more
Participants in the vitamin D arm experienced significant improvement in VAS pain
The effect of vitamin D supplementation on clinical symptoms and metabolic profiles in patients with endometriosis
Mehdizadehkashi A, Rokhgireh S, Tahermanesh K +3 more
Vitamin D supplementation significantly decreased pelvic pain (beta - 1.12; 95% CI, -2.1, -0.09; p=.03)
Effect of Dietary Interventions on Endometriosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meneghetti JK, Pedrotti MT, Coimbra IM +1 more
antioxidant use was associated with a reduction in dysmenorrhea (mean difference - 1.95 [CI 95%, -3.78 to -0.13]
Safety
Caveats
{"Association with severity may reflect reverse causation","No evidence it shrinks lesions or improves fertility","Pain trials are small and inconsistent"}
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.